Since Gal-3 is readily expressed on the cell surface, and easily secreted into biological fluids (e.g., serum and urine) from injured cells and inflammatory cells, recent studies suggest that cardiac Gal-3 could be a marker for cardiac disorders such as cardiac inflammation and fibrosis, depending on the specific pathogenesis of human heart diseases [12,13]. Here, LGALS3 is linked to inflammatory response.